An observational study in Blunt Injuries, sponsored by Chang Gung Memorial Hospital. Completed. Open to participants aged 17 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-05-09.
Sponsored by Chang Gung Memorial Hospital · Observational
This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period in our institution.
The nonoperative management (NOM) protocol with angioembolization (AE) presents a trend in dealing with trauma patients with blunt splenic injury (BSI). This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period.
5,056 studies on the registry are indexed under Wounds and Injuries; 859 are open to participants now.
This study's enrollment of 399 is above the median of 135 across 1,597 observational studies indexed under Wounds and Injuries.
Browse Wounds and Injuries studies →Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 234 are open to participants now.
Counted across the registry records on this site, refreshed daily.
A retrospective study was performed on adult trauma patients with BSI who were admitted from 2005 to 2016. The patients were divided into before cohort (2005-2010) and after cohort (2011-2016).
Exclusion Criteria:
The nonoperative management (NOM) protocol with angioembolization (AE) presents a trend in dealing with trauma patients with blunt splenic injury (BSI). This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period.
Other: Patient before cohort (2005-2010) · Other: Patient after cohort (2011-2016)
The NOM protocol with AE was recognized and accepted after our previous study reported in 2004.
The protocol of NOM became more aggressively and strictly adhered to since 2011.
The numbers of associated complications and mortality
The primary outcome of interest in this study would be the associated complications and mortality.
Time frame: up to 6 months
No study locations are listed for this record.
This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chang Gung Memorial Hospital